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The second type II module from human matrix metalloproteinase 2:
structure, function and dynamics
Klára Briknarová1, Alexander Grishaev1, László Bányai2, Hedvig Tordai2,
László Patthy2 and Miguel Llinás1*
Background: Matrix metalloproteinase 2 (MMP-2, gelatinase A, 72 kDa type IV
collagenase) has an important role in extracellular matrix degradation during cell
migration and tissue remodeling. It is involved in development, inflammation,
wound healing, tumor invasion, metastasis and other physiological and
pathological processes. The enzyme cleaves several types of collagen, elastin,
fibronectin and laminin. Binding to collagen is mediated by three repeats
homologous to fibronectin type II modules, which are inserted in the catalytic
domain in proximity to the active site.
Results: We have determined the NMR solution structure of the second type II
module from human MMP-2 (col-2). The module exhibits a typical type II fold
with two short double-stranded antiparallel β sheets and three large loops
packed around a cluster of conserved aromatic residues. Backbone amide
dynamics, derived from 15N relaxation experiments, correlate well with solvent
accessibility and intramolecular hydrogen bonding. A synthetic peptide with
the collagen consensus sequence, (Pro-Pro-Gly)6, is shown to interact with
the module.
Conclusions: Spectral perturbations induced by (Pro-Pro-Gly)6 binding reveal
the region involved in the interaction of col-2 with collagen. The binding surface
comprises exposed aromatic residues Phe21, Tyr38, Trp40, Tyr47, Tyr53 and
Phe55, and the neighboring Gly33–Gly37 segment.
Introduction
Matrix metalloproteinase 2 (MMP-2), also known as
gelatinase A or 72 kDa type IV collagenase (EC 3.4.24.24),
comprises a prodomain, a catalytic domain, three
fibronectin type II domains and a hemopexin-like domain
[1]. It is secreted as a proenzyme and its activity in the
extracellular environment is modulated by an activator
(membrane-type 1 matrix metalloproteinase [2]) and
several inhibitors (α-macroglobulins and tissue inhibitors
of metalloproteinases [3]). Besides gelatin (denatured col-
lagen) [1] and pepsin-solubilized type IV collagen from
basement membranes [1,4], MMP-2 also cleaves intersti-
tial type I [5] and type V [1] collagen, type VII collagen
found in anchoring fibrils [1], cartilage type X collagen [6],
elastin [7,8], fibronectin [1], vitronectin [9] and laminin-5
[10]. Its proteolytic activity results not only in the removal
of extracellular matrix barriers that limit cell movement,
but also in modulation of cell adhesion [11], migration
[10], proliferation and differentiation [12]. Hence, it is not
surprising that MMP-2 plays an important role in develop-
ment, inflammation, tissue repair, tumor invasion, meta-
stasis, and other processes (reviewed in [13]).
The C-terminal hemopexin-like domain of MMP-2 medi-
ates interaction with inhibitors and the cell surface, and is
essential for activation [14–19]. It is composed of four sub-
domains arranged as a four-bladed propeller [20,21]. X-ray
and nuclear magnetic resonance (NMR) structures of the
catalytic domain of homologous MMPs [22–31] reveal two
subdomains separated by an active-site cleft, and a cat-
alytic zinc ion coordinated by three histidyl residues and a
water molecule. In the latent state, a prodomain folds over
the active site and contributes a cysteine thiol group,
which coordinates the zinc and displaces the water mol-
ecule. This interaction can be disrupted by chaotropic
agents, organomercurials or proteolysis. Once the active
site is free, MMP-2 undergoes autolytic cleavage, resulting
in the loss of the prodomain [13].
MMP-2 and the closely related MMP-9 (gelatinase B,
92 kDa type IV collagenase) are unique among the
metalloproteinases in that three fibronectin type II
modules are inserted in their catalytic domains in the
vicinity of the active site. Homologous repeats are found
as single or double copy in various other proteins, includ-
ing fibronectin, mannose receptor, phospholipase A2
receptor, factor XII, hepatocyte growth factor activator,
mannose-6-phosphate receptor, DEC-205 receptor and
bovine seminal fluid proteins A3 and PDC-109 [32,33].
The type II modules account for the affinity of MMP-2 for
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gelatin, type I and IV collagen, elastin and laminin
[34–39]. Their absence results in a decrease of gelati-
nolytic activity [37], a different cleavage pattern of type IV
collagen [37] and loss of activity towards elastin [36]. The
first, second and third modules bind gelatin with apparent
association constants (Kas) of ~0.4 mM–1, ~1.6 mM–1 and
~1.3 mM–1, respectively [35]. Several residues that are
important for interaction with gelatin have been identified
on the basis of site-directed mutagenesis of the second
type II modules from MMP-2 [40] and MMP-9 [41]. Also,
a number of residues involved in binding of small
hydrophobic ligands to the related second module of
PDC-109 (PDC-109/b) were inferred from 1H NMR
studies [42]. The structures of PDC-109/b [42] and the
first and second type II modules from human fibronectin
[43,44] have been determined using NMR spectroscopy.
In order to characterize the structure and function of the
multidomain gelatin-binding site of human MMP-2, we
have undertaken a study of its component modules. Here,
we report the NMR solution structure of the second type
II module (col-2) (Figure 1) and discuss its dynamic
behavior. We also present a detailed analysis of the inter-
action between col-2 and (Pro-Pro-Gly)6, henceforth
denoted as (PPG)6, a peptide mimic of gelatin.
Results and discussion
Resonance assignments and structure determination
Restraints for 844 interproton distances (186 long-range,
5 ≤ |i–j|, 58 medium-range, 2 ≤ |i–j| ≤ 4, 180 sequential and
420 intraresidual), 10 hydrogen-bond distances, and 25 φ,
3 ψ and 24 χ1 dihedral angles were derived, as described
in the Materials and methods section. Using these
restraints, 50 structures were calculated (Figure 2a); statis-
tics for the ensemble are summarized in Table 1. Overall,
the structures agree well with the experimental data and
exhibit good covalent geometry. A model with particularly
low restraint violations and good geometry (Table 1) was
selected for subsequent discussion and illustrations.
Restraints for 844 interproton distances (186 long-range,
5 ≤ |i–j|, 58 medium-range, 2 ≤ |i–j| ≤ 4, 180 sequntial and
420 intraresidual), 10 hydrogen-bond distances, and 25 φ,
3 ψ and 24 χ1 dihedral angles were derived, as described
in the Materials and methods section. Using these
restraints, 50 structures were calculated (figure 2a); statis-
tics for the ensemble are summarized in Table 1. Overall,
the structures agree well with the experimental data and
exhibit good covalent geometry. A model with particularly
low resraint violations and good geometry (Table 1) was
selected for subsequent discussion and illustrations.
Structure of col-2
The module consists of two short double-stranded
antiparallel β sheets (Phe19–Phe21/Thr24–Tyr26 and
Trp40–Gly42/Tyr53–Phe55), arranged approximately
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Figure 1
The primary structure of col-2. Residues are numbered 1–60,
consistent with previous use [43,44]. The N-terminal threonine residue
originates from the expression vector. Disulfide bonds are indicated.
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Figure 2
The NMR structure of col-2, residues 3–58,
and comparison with homologous type II
modules. (a) The superposed backbone
traces of 50 calculated col-2 structures are
shown in black; the mean structure is colored
red. (b) Superposed backbone traces of col-2
(red), the first (blue) and second (green) type
II modules from human fibronectin [43,44].
The orientation of the molecules in (a) and (b)
is the same.
perpendicular to each other, and three large irregular
loops (Figure 3). The first loop includes the N-terminal
residues which precede the first disulfide bridge. The
second loop links the two β sheets. The third loop con-
nects the strands of the second β sheet and contains an 
α-helical turn (Tyr47–Asp50). The first β sheet and the
loops are arranged around the second β sheet, forming a
large cavity filled with aromatic sidechains of Phe17,
Phe19, Phe21, Tyr26, Tyr38, Trp40, Tyr47, Tyr53 and
Phe55. Phe19 is totally buried, consistent with its hin-
dered motion on the NMR timescale and the resulting
distinct broad HδX, HεX and HδY, HεY resonances. Phe21,
Tyr38, Trp40, Tyr47, Tyr53 and Phe55 form an extended
hydrophobic surface, whereas Phe17 faces the other side
of the module (Figures 4a,b). Inspection of the model
(front view) reveals two clusters of electrostatic charges
that sandwich the hydrophobic cleft: a major one, orien-
tated lengthwise at the left side of the hydrophobic cleft,
is integrated by residues Lys16, Lys51, Arg20, Arg49,
Asp46, Asp48, Asp50, Glu11 and Glu45; the other, at the
right side of the hydrophobic cleft, is contributed to by
residues Arg34 and Arg39, surrounded by Asp36, Glu32
and Glu58 (Figures 4c,d). Asp27, on the upper back side
relative to the hydrophobic cleft, is placed in between the
two ionic clusters.
The Cys15–Cys41 and Cys29–Cys56 disulfide bridges and
both the N and C termini are located at the back of the
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Table 1
Structural statistics for col-2.
Ensemble Selected structure
Rmsd from experimental restraints
NOE distance restraints (Å) 0.072 ± 0.007 0.065
dihedral angle restraints (°) 0.3 ± 1.0 0
Number of experimental restraint violations
NOE violations > 0.5 Å 1.6 ± 1.2 1
dihedral angle violations > 5° 0.1 ± 0.3 0
Rmsd from idealized geometry*
bonds (Å) 0.0202 ± 0.0002 0.0199
angles (°) 2.9 ± 0.1 2.8
impropers (°) 2.9 ± 0.4 2.9
Rmsd of residues 3–58 from mean coordinates†
backbone atoms (N, Cα, C) (Å) 0.8 ± 0.2 0.7
heavy atoms (Å) 1.3 ± 0.2 1.2
Distribution of φ, ψ dihedral angles‡
most favored regions (%) 73.7 83.0
additional allowed regions (%) 21.6 14.9
generously allowed regions (%) 2.9 2.1
disallowed regions (%) 1.7 0.0
*Idealized covalent geometry is based on the parallhdg.pro forcefield in X-PLOR [73]. †Mean coordinates were obtained by averaging coordinates
of the 50 calculated structures, which were first superposed using backbone atoms (N, Cα, C) of residues 3–58. ‡As determined by analysis of the
Ramachandran plot [74]. Rmsd, root mean square deviation.
Figure 3
Ribbon representation of col-2 (residues
3–58) showing the secondary structure and
aromatic cluster. (a) Front and (b) side view.
β Sheets are represented by purple arrows,
an α-helical turn is displayed in red, and
disulfide bridges are in yellow. Aromatic
sidechains in the front view are colored cyan.
Phe4 and Phe17, which face the back, are
omitted for clarity. 
second β sheet, on the side opposite from the aromatic
cluster (Figure 3). Overall, the col-2 structure exhibits a
typical type II fold [42], analogous to those of the first and
second type II modules from human fibronectin [43,44]:
pairwise root mean square deviations (rmsds) of super-
posed backbone atoms of residues 3–58 are 1.51 Å and
1.46 Å, respectively (Figure 2b).
Interaction of col-2 with a gelatin-like peptide
Collagen exhibits a characteristic repetitive primary struc-
ture: every third residue is glycine and prolines are abun-
dant at the other positions [46]. Hence, a peptide with the
consensus sequence (PPG)6 [47,48] was synthesized, and
its interaction with col-2 was investigated. Chemical-shift
changes induced by (PPG)6 binding were monitored via
two-dimensional (2D) chemical shift correlated spec-
troscopy (COSY; data not shown) and 1H–15N HSQC
(Figure 5) experiments. From the ligand titration profile
(Figure 6), it was determined that the peptide interacts
with col-2 with a Ka of ~0.36 ± 0.02 mM–1. As col-2–peptide
cross-peaks were not apparent in a 2D NOESY spectrum,
the interface could not be mapped via interproton distance
restraints. However, a rough picture of the col-2 binding
surface can be generated by localizing the ligand-induced
spectral perturbations on the 3D structure of the module
(Figure 7). Notably, residues with the most perturbed
backbone amide resonances are limited to a band that runs
diagonally across the front side of col-2, comprising the aro-
matic cluster and surrounding areas. An apparent exception
is Thr43, which faces the back of the module. As the
amide group of this residue is buried, however, this effect
probably reflects a relay of perturbation from the aromatic
cluster via the interior of the molecule. Backbone amide
resonances from aromatic residues exposed on the front
side are significantly more sensitive to peptide binding
than resonances of aromatic residues that are internal or
face the back: Tyr47 > Phe21 > Trp40 > Tyr53 > Tyr38 >
Tyr26 > Phe55 > Phe19 > Phe4 > Phe17. In a similar
fashion, resonances of aromatic ring protons from Phe21,
Tyr38, Trp40, Tyr47, Tyr53 and Phe55 are affected by
peptide binding, whereas those of Phe17, Phe19 and
Tyr26 shift minimally (data not shown). Overall, the data
indicate that the bound peptide extends along the aromatic
cluster, interacting with Phe21, Tyr38, Trp40, Tyr47,
Tyr53 and Phe55 on the front face of the module.
The stretch of Gly33–Tyr38, which protrudes over the aro-
matic cluster on the front side of col-2 (most evident in
Figure 3b), is also sensitive to (PPG)6 binding. The back-
bone amide resonances of Gly33 and Arg34 are particularly
1238 Structure 1999, Vol 7 No 10
Figure 4
Contact surface of col-2, residues 3–58,
colored according to (a,b) residue
hydrophobicity [83] and (c,d) electrostatic
potential. Front (a,c) and back (b,d) views are
shown. In parts (a) and (b) the darker the
yellow the greater the hydrophobicity. In parts
(c) and (d) areas of negative, positive and
neutral electrostatic potential are depicted in
red, blue and white, respectively.
perturbed (Figures 5,7), and the εNH group of Arg34 is
even more markedly affected — its εH and εN resonances
shifting by 0.96 ppm and 1.61 ppm, respectively
(Figure 5). This suggests that ligand binding somewhat
alters the conformation of the region, modifying the inter-
action between the conserved sidechains of Arg34 and
Asp36 (Figures 4c,d).
In addition, the backbone amide resonances of several
residues in the first β sheet and the connecting type I′
β turn (Arg20-Phe21-Gln22-Gly23) experience significant
shifts upon (PPG)6 binding (Figures 5,7). Yet, whereas the
aromatic ring of Phe21 (discussed above) and the εNH2
group of Gln22 are affected, the εNH of Arg20 is not
(Figure 5). Therefore, we speculate that the interaction of
the ligand with the aromatic cluster induces subtle
changes in the configuration of the β sheet–β turn, with
not all sidechains within the Arg20–Gly23 segment neces-
sarily being involved in the binding. The situation is
somewhat analogous for residues in the N-terminal loop
that come into contact with the lower part of the aromatic
cluster: Gly8 and the δNH2 group of Asn9 are likely to
relay perturbation from Tyr53, whereas Met6 is proximal
to Tyr38.
Comparison with previous ligand-binding studies
We have reported elsewhere on the interaction between
PDC-109/b and a small hydrophobic molecule,
3,3-dimethylbutylamine [42]. Two distinct ligand-per-
turbed areas were identified in PDC-109/b by 1H NMR:
one comprises Tyr7, Trp26, Tyr33 and Trp39 with the
neighboring residues Ile18, Asp34 and Ala38 (correspond-
ing to Phe21, Trp40, Tyr47, Tyr53, Glu32, Asp48 and
Lys52 in col-2); the other consists of Trp23 and Met24
(Asp36 and Gly37 in col-2). Counterparts of both regions
in col-2 belong to the (PPG)6-binding area, and it seems
likely that PDC-109/b exploits an analogous continuous
surface for interaction with large ligands, whereas small
Research Article  Col-2 structure, function and dynamics Briknarová et al. 1239
Figure 5
1H–15N HSQC of col-2 and the effect of
(PPG)6 binding. The spectra of ligand-free
col-2 (black) and col-2 in the presence of an
18-fold molar excess of (PPG)6 (red) are
superimposed; the most noticeable cross-
peak shifts are indicated with arrows.
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molecules (like the 3,3-dimethylbutylamine mentioned
above) bind to separate subsites of this surface. No pertur-
bation of residues equivalent to the col-2 segment
Gly33–Thr35 was observed in PDC-109/b. However, the
Arg34/Asp36 pair found in col-2 is not conserved in PDC-
109/b, suggesting that the Gly33–Tyr38 stretch in col-2
may differ structurally and functionally.
Alanine mutations of Arg307, Asp309, Trp313, Cys314,
Asn319, Tyr320 and Asp323 in the second type II module
of MMP-9 (corresponding to Arg34, Asp36, Trp40, Cys41,
Asp46, Tyr47 and Asp50 in col-2) led to virtually complete
loss of binding affinity for gelatin [41]. However, little can
be inferred about involvement of these residues in gelatin
binding as structural integrity of the mutants was not
reported. Alanine mutations of Gln295, Glu297 and
Ser298 (corresponding to Gln22, Thr24 and Ser25 in col-2)
did not affect affinity for gelatin. This concurs with our
observations for Thr24 and Ser25, and supports our con-
clusion that some sidechains from the β sheet–β turn
segment Arg20–Gly23 are unlikely to be in direct contact
with the ligand. Mutation of Tyr311 and Arg312 (Tyr38
and Arg39 in col-2) to alanine also did not interfere with
gelatin binding, in line with our results for Arg39 but in
apparent contradiction with those for Tyr38.
In the case of col-2, mutagenesis studies [40] have shown
that Tyr26, Tyr47, Asp50 and Tyr53 are necessary for
correct folding. Mutation of Arg20 and Arg39 to leucine,
and mutation of Lys51 to glycine or arginine did not
affect the affinity of the module for gelatin, consistent
with our observation that sidechain resonances from these
residues are not perturbed by (PPG)6. Mutation of Tyr38
to alanine impaired gelatin binding without detectable
effect on the structure, which concurs with our result that
Tyr38 is affected by the interaction, and contrasts with
the data for MMP-9 mentioned above. However, it is con-
ceivable that the gelatin-binding areas of type II modules
from MMP-2 and MMP-9 differ in detail, particularly
towards the periphery.
Characterization of col-2 dynamics
The backbone dynamics of col-2 were assessed from 15N
longitudinal (R1) and transverse (R2) relaxation rates and
the steady-state 1H–15N NOE (X-NOE), using the model-
free approach [49,50]. Under the experimental conditions,
the overall rotational correlation time of the molecule was
estimated to be ~4.83 ± 0.02 ns. The backbone appears to
be well ordered, except for the termini (Figures 8,9).
Within the structured core, the lowest value of the order
parameter (S2) is exhibited by the amide of Arg39, which
happens to point towards the C terminus and thus may be
perturbed by motions of Glu58. Most variations of S2 cor-
relate with the HN solvent accessibility and H/D exchange
1240 Structure 1999, Vol 7 No 10
Figure 6
NMR-monitored titration of col-2 with (PPG)6. Normalized col-2
resonance shifts (∆δ), corresponding to the fraction of ligand-bound
protein, are plotted versus [Lo]/[Po], the concentration ratio of total
ligand to total protein. Each point is an average of nine selected amide
1H or 15N resonance shifts. The continuous trace represents the
calculated binding curve.
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Figure 7
The contact surface of col-2, residues 3–58,
colored according to backbone amide
chemical-shift changes induced by (PPG)6
binding. (a) Front and (b) back views. The
color intensity is proportional to the sum of
median-normalized amide 1H and 15N
chemical-shift changes of the individual
residues, and is scaled in order to achieve a
balanced distribution. Maximum intensity is
used for nine residues with the most perturbed
amides. For Pro14, Pro18, Thr35 and Pro57,
the color intensities represent an average of
those calculated for neighboring residues. 
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Figure 8
Backbone amide dynamics of col-2. (a) H/D
exchange rate, (b) generalized order
parameter S2, (c) average backbone heavy-
atom (N, Cα, C′) rmsd and (d) average amide
proton solvent accessibility. The secondary
structure is outlined at the top. In (a) residues
with backbone amide proton resonances
observable 1.5 h after dissolving the protein in
D2O are indicated by black squares. Small
circles denote Gly42, the exchange rate of
which was not assessed because of spectral
overlap, and proline residues. In (b), all S2
values are shown for residues with double or
multiple backbone amide resonances.
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Figure 9
Contact surface of col-2, residues 3–58,
colored according to backbone amide order
parameter S2. (a) Front and (b) back views.
Maximum color intensity denotes residues with
low order parameter (Leu3, Arg39 and Glu58;
S2 < 0.71); white indicates the least mobility
(Phe55; S2 = 0.91). For residues with double
or multiple backbone amide resonances, S2
was averaged. For proline residues, the color
intensities represent an average of those
calculated for neighboring residues.
rates (e.g. segments Glu13–Glu32 and Trp40–Phe55;
Figure 8). It is likely that exposed amides have inherently
more space for local motion and/or are affected by inter-
action with solvent (H2O) molecules. An exception is the
Gly33–Tyr38 stretch, within which all amides display rela-
tively low S2, regardless of solvent accessibility. These
residues project away from the core of the module
(Figure 3b) and their conformation is somewhat less
defined than that of the compact core (Figure 8c). As this
region is involved in gelatin binding, its flexibility may
reflect functional adaptability to the ligand.
Biological implications
Localized degradation of the extracellular matrix is
essential for cell migration and tissue remodeling during
development, inflammation, wound healing, tumor inva-
sion, metastasis and other physiological and pathological
processes. It involves a variety of proteolytic enzymes,
including plasminogen and its activators, and the matrix
metalloproteinases. Matrix metalloproteinase 2 (MMP-2)
cleaves several types of collagen, gelatin, elastin,
fibronectin and laminin. Binding of MMP-2 to extracellu-
lar matrix proteins is mediated by three type II modules,
which are inserted in the catalytic domain near the
active site.
Here we report the solution structure of the second type
II module from human MMP-2 and show that it interacts
with the peptide (Pro-Pro-Gly)6. The collagen-binding
surface of col-2, as mapped by 1H/15N NMR chemical-
shift perturbations induced by the peptide, comprises an
area lined by conserved aromatic residues Phe21, Tyr38,
Trp40, Tyr47, Tyr53 and Phe55, and flanked by an over-
hanging segment of Gly33–Gly37. The measured associa-
tion constant, Ka ~0.36 ± 0.02 mM–1, is somewhat less
than that for the binding of col-2 to gelatin (apparent
Ka ~1.6 mM–1 [35]). This suggests that nonproline
sidechains play a role in the interaction of gelatin with
col-2, even though the consensus sequence (Pro-Pro-
Gly)6 displays enough determinants to be specifically rec-
ognized. Despite the weak nature of the binding, it is
physiologically significant. Similarly to plasmin, which
interacts dynamically with macromolecular substrates
such as fibrin, it is not advantageous for MMP-2 to
remain localized at a single site in the extracellular envi-
ronment. In order to perform its function efficiently, it
has to diffuse through the meshwork it is degrading. The
concomitant action of three weakly binding type II
modules guarantees that MMP-2 preserves some mobil-
ity while being effectively retained close to its substrates.
Materials and methods
Expression and purification of col-2
The second fibronectin type II module from human MMP-2 (residues
278–336), preceded by a 35 amino acid long peptide derived from the
β-galactosidase moiety of the expression vector [40], was produced in
Escherichia coli. Growth of bacteria, isolation of inclusion bodies and
refolding of the recombinant protein were performed essentially as
described previously [34]. A properly folded, functionally homogeneous
module was isolated on a gelatin–sepharose 4B column using a 0–8 M
urea gradient [35]. The β-galactosidase moiety was removed by limited
trypsin digestion: the protein (1 mg/ml) in 0.1 M ammonium bicarbon-
ate buffer pH 8.0 was incubated with 0.001 mg/ml trypsin (Sigma) at
25°C for 60 min. The reaction was arrested with 2 mM phenylmethyl-
sulfonyl fluoride (Serva), and the digest was separated on a
gelatin–sepharose 4B column with urea gradient as above. Finally, the
protein was purified on a sephadex G-25 column in 0.1 M ammonium
bicarbonate. Sequence analysis has shown that the cleavage occurred
close to the fusion boundary, leaving only one extraneous residue, thre-
onine, at the N terminus of the type II module.
In order to obtain 15N-labeled protein, the bacteria were first grown
overnight at 37°C in 100 ml of 2TY medium containing 0.1 mg/ml
ampicillin. The cells were harvested by centrifugation and washed
twice with 50 mM Tris-HCl buffer pH 8.0. The pellet was resuspended
in 1 l minimal medium containing 1 g [15N]NH4Cl (ISOTEC, Inc.), and
the cells were grown at 37°C for 1 h. Expression of the recombinant
protein was then induced with 10 mM lactose (REANAL, Budapest).
After 96 h at 37°C, the bacteria were harvested and the recombinant
protein was isolated and truncated as described above for the unla-
beled material. Electrospray ionization mass spectrometry (ESI-MS)
confirmed the purity of the unlabeled protein and indicated that the
15N-labeled sample contained both a protein with the expected mass,
6,841.2 Da, and a second species of 6857.3 Da, which we tentatively
assign to col-2 oxidized at Met6. 
NMR spectroscopy and structure calculations
All the data were acquired at 25°C on Bruker Advance DMX-500 and
DMX-600 spectrometers equipped with 5 mm triple-resonance gradient
probes. Sequential assignments were initially obtained for a sample of
1.3 mM unlabeled col-2 in 90% H2O/10% D2O pH 5.2, based on 2D
homonuclear COSY [51], TOCSY [52] (with MLEV-17 mixing sequence
[53], mixing time 70 ms) and NOESY [54] (mixing times 60, 120 and
200 ms) spectra. The experiments were recorded with standard pulse
sequences and phase cycles (XWIN-NMR version 2.0, Bruker,
Germany). Solvent suppression in COSY was achieved by selective low-
power irradiation (presaturation) during the relaxation delay; in TOCSY
and NOESY, the WATERGATE scheme [55,56] was used. 
For H/D exchange studies, the protein was lyophilized and redisolved
in 99.995% D2O pH 5.1 (uncorrected pH meter reading). The
exchange kinetics was then monitored by one-dimensional (1D) and
short 2D TOCSY (mixing time 75 ms) experiments. NOESY (mixing
time 120 ms) and E-COSY [57] spectra were also acquired.
Assignments were confirmed and extended on the basis of 2D
1H–15N HSQC [58–60], 3D 15N-edited TOCSY (mixing time 75 ms),
3D 15N-edited NOESY (mixing time 150 ms) [61–64], 3D HNHA [65]
and 3D HNHB [66,67] experiments, which were recorded for samples
of 1 mM and 4 mM 15N-labeled col-2 in 90% H2O/10% D2O pH 5.2. 
All spectra were processed and analyzed with the program Felix 95
(Molecular Simulations, Inc., San Diego, CA) on a Silicon Graphics
Indy R-5000 workstation. The baseline was corrected with a model-
free algorithm developed by Friedrichs [68]. Proton chemical shifts
were referenced using p-dioxane (δ = 3.75 ppm) as an internal stan-
dard [69], 15N chemical shifts were referenced indirectly [70].
Cross-peak volumes from 2D NOESY (mixing time 60 ms), after cor-
rection for the WATERGATE excitation profile, were converted to inter-
proton distances with the program Felix 95. To calibrate the r–6
relationship between volumes and distances, well resolved cross-peaks
between intraresidual methylene or tryptophan aromatic protons were
used. Upper and lower distance restraints were generated by adding or
subtracting 20% of the calculated distance, respectively. Redundant
intraresidual restraints were retained. No restraints were applied to the
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first or last two residues as they yielded only trivial (intraresidual and
sequential) NOEs, and the relaxation data indicated that they were
highly flexible.
Hydrogen-bond restraints were introduced to reinforce hydrogen
bonds that were detected in the secondary structures of preliminary
models and which were supported by characteristic NOE patterns and
slow amide H/D exchange rates.
3JHNHα values were calculated from cross-peak/diagonal peak intensity
ratios in a 3D HNHA experiment [65]. The φ dihedral angles were
restrained to the range of –120° ± 50° for 3JHNHα > 8 Hz, –120° ± 40°
for 3JHNHα > 9 Hz, and –60° ± 30° for 3JHNHα < 5 Hz. Clear Hα(i–1)
cross-peaks in 3D HNHB, corresponding to 3JNHα(i–1) < –1.2 Hz, indi-
cated that N is trans to Hα(i–1) [66], and the relevant ψ dihedral angles
were confined to –60° ± 60°. Stereospecific assignments and χ1 dihe-
dral angle restraints were based on 3JHαHβ estimates from E-COSY,
and 3JNHβ values from cross-peak/diagonal peak intensity ratios in a 3D
HNHB spectrum [66]. The individual χ1 rotamers were restrained to
–60° ± 30°, 60° ± 30° and 180° ± 30°, respectively.
50 structures were generated with a standard distance geometry/simu-
lated annealing protocol [71,72] implemented in the program X-PLOR,
version 3.851 [73]. All structures were retained and further minimized
with the program CHARMM 23.1 within the Quanta 96 package (Mol-
ecular Simulations, Inc., San Diego, CA). Full nonbonded potential
including the Lennard–Jones, electrostatic and hydrogen-bond terms
was used. The calculations were performed on a Silicon Graphics Indy
R-5000 workstation. The quality of the structures was assessed with
the program PROCHECK v.3.4.4 [74]. Structural properties were ana-
lyzed with the programs X-PLOR and MOLMOL [75]. MOLMOL was
also used for display and presentation.
Ligand-binding studies
A model gelatin-like peptide (PPG)6 was synthesized on an AB-PE
431A peptide synthesizer (Applied Biosystems—Perkin Elmer, Foster
City, USA), using Fmoc chemistry. Small aliquots of the peptide stock
solution in H2O pH 7.0 were added to a sample of 0.6 mM 15N-labeled
col-2 in 90% H2O/10% D2O pH 7.0, up to ~18-fold molar peptide
excess. An 1H–15N HSQC experiment was recorded at each step to
monitor the ligand-induced resonance shifts. In order to see the
response of nonamide protons, COSY, TOCSY (with DIPSI-2 mixing
sequence [76,77], mixing time 75 ms) and NOESY (mixing time
200 ms) experiments with 15N decoupling were acquired at zero and
final peptide concentration. The equilibrium association constant was
determined by a combination of linear and nonlinear least-squares
fitting of the chemical-shift changes, as described previously [78,79].
Backbone amide dynamics
Steady-state 1H–15N X-NOE and 15N longitudinal (R1) and transverse
(R2) relaxation rates were determined from 2D heteronuclear NMR
experiments [80] for a sample of 4 mM 15N-labeled col-2 in 90%
H2O/10% D2O pH 5.2. The program Felix 97 (Molecular Simulations,
Inc., San Diego, CA) was used to measure peak heights, fit relaxation
decays and estimate uncertainties. The relaxation data were then ana-
lyzed with the program Modelfree, version 3.1 [49,50,81]. An initial
estimate of the overall correlation time was obtained from the trimmed
mean of the R2/R1 ratio [82]. After a parsimonious model was
selected for each resonance, as described in [81], model-free parame-
ters were optimized.
Accession numbers
The coordinates of 50 col-2 structures have been deposited in the
Brookhaven Protein Data Bank with accession code 1CXW.
Supplementary material
Supplementary material including a table of 1H and 15N chemical shifts
of col-2, determined at pH 5.2, 25°C, is available at http://current-
biology.com/supmat/supmatin.htm.
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Table S1
Table of 1H and 15N chemical shifts of col-2 at 25°C and at pH 5.2*.
Residue chemical shift (ppm)
N HN Hα Hβ Other
Thr1 3.89 4.17 Hγ2 1.39
Ala2 128.4 8.75 4.25 1.04
Leu3 124.9 8.60 4.46 1.50/1.62 Hγ 1.62, Hδ1/δ2 0.98/1.05 
Phe4 120.9 7.86 4.10 2.92, 3.26 Hδ1/δ2 7.35, Hε1/ε2 7.35, Hζ 7.35
Thr5 108.4 6.70 4.64 4.05 Hγ1 5.50, Hγ2 0.98
Met6 115.4 8.58 4.87 1.96/2.05 Hγ2/γ3 2.53, Hε 2.05
Gly7 107.7 8.58 3.85/4.17
Gly8 107.6 8.60 3.19/3.28
Asn9 120.3 7.58 5.00 3.33, 2.69 Nδ2 107.4, Hδ21 7.50, Hδ22 7.84
Ala10 119.4 7.13 4.15 1.24
Glu11 116.7 8.91 3.78 2.13/2.18
Gly12 107.1 9.29 3.97/4.09
Gln13 118.2 7.28 4.35 1.87, 2.35 Hγ2/γ3 2.56/2.68, Nε2 113.0, Hε21 7.68, Hε22 6.87
Pro14 4.80 1.64, 1.33 Hγ2/γ3 1.60/1.78, Hδ2/δ3 3.72
Cys15 115.5 7.92 3.95 1.72, 1.54
Lys16 125.8 8.23 4.19 1.00, 1.47 Hγ2/γ3 1.08/1.16, Hδ2/δ3 1.60/1.67, Hε2/ε3 3.01, Hζ 7.61
Phe17 118.0 7.97 5.64 2.82, 3.09 Hδ1/δ2 7.36, Hε1/ε2 7.11, Hζ 7.57
Pro18 5.58 1.88, 2.32 Hγ2/γ3 1.96, Hδ2/δ3 3.57/3.75
Phe19 114.9 8.71 5.59 3.15, 3.99 HδΧ 7.11, HδΥ 8.08, HεΧ 6.47, HεΥ 7.38, Hζ 6.33
Arg20 120.7 8.35 5.40 1.96 Hγ2/γ3 1.58/1.67, Hδ2/δ3 3.22, Nε 84.0, Hε 7.45, 
Nη1/2 71.3, Hη11/η12/η21/η22 6.75
Phe21 123.0 9.36 5.56 3.58, 3.18 Hδ1/δ2 7.48, Hε1/ε2 7.36, Hζ 7.35
Gln22 133.3 11.72 3.78 1.62, 1.97 Hγ2/γ3 1.21/1.65, Nε2 111.2, Hε21 7.21, Hε22 6.88 
Gly23 103.7 8.98 3.59/4.20
Thr24 118.7 7.97 4.44 4.14 Hγ2 0.81
Ser25 119.4 8.38 4.74 3.59/3.62
Tyr26 126.2 9.11 4.29 1.45, 2.68 Hδ1/δ2 7.00, Hε1/ε2 7.07
Asp27 119.6 8.45 4.69 2.61
Ser28 111.1 7.56 3.54 3.76, 3.61
Cys29 114.9 8.48 4.71 3.64, 2.78
Thr30 116.4 8.83 4.97 3.76 Hγ2 0.04
Thr31 113.3 8.13 5.00 4.59 Hγ2 1.11
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Table S1 continued
Table of 1H and 15N chemical shifts of col-2 at 25°C and pH 5.28.
Residual chemical shift (ppm)
N HN Hα Hβ Other
Thr31 113.3 8.13 5.00 4.59 Hγ2 1.11
Glu32 124.9 8.76 4.27 2.22 Hγ2/γ3 2.70
Gly33 109.5 9.03 3.95/4.44
Arg34 116.7 8.00 4.81 2.10, 2.25 Hγ2/γ3 1.20/1.44, Hδ2/δ3 2.89/3.44, Nε 83.9, Hε 9.24,
Nη1/η2 70.7, Hη11/η12/η21/η22 6.54
Thr35 109.8 8.98 4.67 4.54 Hγ2 1.19
Asp36 118.9 7.68 4.56 2.81, 2.55
Gly37 107.4 8.35 3.73/4.02
Tyr38 120.0 7.72 4.63 2.90/2.93 Hδ1/δ2 6.84, Hε1/ε2 6.67
Arg39 120.1 8.51 4.70 2.00, 1.60 Hγ2/γ3 1.51/1.86, Hδ2/δ3 3.26, Nε 83.9, Hε 7.36, 
Nη1/η2 71.9, Hη11/η12/η21/η22 6.85
Trp40 123.3 9.84 5.63 3.32, 2.87 Hδ1 7.37, Nε1 129.3, Hε1 9.99, Hε3 6.81, Hζ3 5.50, 
Hη2 5.30, Hζ2 5.92
Cys41 111.1 8.93 4.15 2.85, 3.01
Gly42 104.1 3.62 4.75, 3.12
Thr43 109.9 7.81 4.34 4.25 Hγ1 4.74, Hγ2 0.61
Thr44 111.8 7.80 4.49 4.48 Hγ2 1.16
Glu45 112.4 9.00 4.47 2.16/2.28 Hγ2/γ3 2.44
Asp46 120.4 7.96 5.18 2.38, 2.96
Tyr47 127.2 9.12 5.32 3.29, 3.85 Hδ1/δ2 7.38, Hε1/ε2 6.48
Asp48 119.9 7.86 4.33 3.10, 2.74
Arg49 117.2 7.64 4.12 1.66/1.73 Hγ2/γ3 1.47, Hδ2/δ3 3.13/3.31, Nε 85.6, Hε 7.75, 
Nη1/η2 71.5, Hη11/η12/η21/η22 7.01
Asp50 115.7 8.24 4.56 2.86, 2.65
Lys51 115.6 9.02 2.85 1.86, 1.77 Hγ2/γ3 1.00/1.16, Hδ2/δ3 1.37/1.46, Hε2/ε3 3.00, Hζ 7.49
Lys52 118.6 7.93 5.36 1.79, 1.60 Hγ2/γ3 1.32, Hδ2/δ3 1.37/1.57, Hε2/ε3 2.91, Hζ 7.50
Tyr53 124.1 9.72 5.54 3.00/3.04 Hδ1/δ2 6.64, Hε1/ε2 6.37
Gly54 103.7 8.06 3.35/3.82
Phe55 115.6 8.82 5.23 3.06, 3.30 Hδ1/δ2 7.47, Hε1/ε2 7.29, Hζ 7.38
Cys56 119.9 8.71 4.82 3.38, 3.13
Pro57 4.55 2.00, 2.36 Hγ2/γ3 2.00, Hδ2/δ3 3.66/4.05
Glu58 121.1 8.78 4.37 2.02/2.15 Hγ2/γ3 2.43
Thr59 113.8 8.09 4.37 4.30 Hγ2 1.23
Ala60 131.3 8.02 4.19 1.39
*Slash (/) denotes ambiguity. α- and β-methylene protons are listed in the order Hα2, Hα3 or Hβ2, Hβ3, respectively.
